Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diagnostic imaging of the reticuloendothelial system (RES) and lymphatic tissue utilizes gamma-emitting radiotracers, such as technetium-99m labeled colloids, to visualize these systems. The RES, composed of macrophages in the liver, spleen, and bone marrow, phagocytoses these tracers, allowing for assessment of organ function. Lymphatic imaging involves interstitial injection of tracers that drain into lymph nodes, enabling mapping of lymphatic pathways, particularly for sentinel lymph node biopsy in cancer staging. This technique provides functional information about tracer uptake and distribution, aiding in the diagnosis and management of various diseases.
Diagnostic imaging through selective uptake or transport of gamma-emitting radiotracers, enabling visualization of the RES and lymphatic systems via gamma camera or SPECT scanning.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reticuloendothelial System and Lymphatic Tissue (RES/Lymphatics).